Cramer: Mea culpa! This stock's action is why I say small-cap biotechs are only for speculation

Jim Cramer admits he was too eager about the stock of Alder BioPharmaceuticals, which just took a huge hit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.